1081 related articles for article (PubMed ID: 10831062)
1. Association between blood rheology, thrombosis and cancer survival in patients with gynecologic malignancy.
von Tempelhoff GF; Nieman F; Heilmann L; Hommel G
Clin Hemorheol Microcirc; 2000; 22(2):107-30. PubMed ID: 10831062
[TBL] [Abstract][Full Text] [Related]
2. Blood rheology at term in normal pregnancy and in patients with adverse outcome events.
von Tempelhoff GF; Velten E; Yilmaz A; Hommel G; Heilmann L; Koscielny J
Clin Hemorheol Microcirc; 2009; 42(2):127-39. PubMed ID: 19433886
[TBL] [Abstract][Full Text] [Related]
3. Aggregability and disaggregability of erythrocytes in women suffering from ovarian cancer: evidence for an increased disaggregation threshold.
El Bouhmadi A; Laffargue F; Brun JF
Clin Hemorheol Microcirc; 2000; 22(2):91-7. PubMed ID: 10831060
[TBL] [Abstract][Full Text] [Related]
4. Soluble urokinase plasminogen activator receptor in preoperatively obtained plasma from patients with gynecological cancer or benign gynecological diseases.
Riisbro R; Stephens RW; Brünner N; Christensen IJ; Nielsen HJ; Heilmann L; von Tempelhoff GF
Gynecol Oncol; 2001 Sep; 82(3):523-31. PubMed ID: 11520150
[TBL] [Abstract][Full Text] [Related]
5. Gynecologic cancers: factors affecting survival after pulmonary metastasectomy.
Clavero JM; Deschamps C; Cassivi SD; Allen MS; Nichols FC; Barrette BA; Larson DR; Pairolero PC
Ann Thorac Surg; 2006 Jun; 81(6):2004-7. PubMed ID: 16731120
[TBL] [Abstract][Full Text] [Related]
6. Blood fluidity and outcome after femoropopliteal percutaneous transluminal angioplasty (PTA): role of plasma viscosity and low platelet count in predicting restenosis.
van der Loo B; Kovacevic T; Krieger E; Banyai S; Banyai M; Amann-Vesti BR; Jagacic D; Rousson V; Koppensteiner R
Clin Hemorheol Microcirc; 2005; 32(2):159-68. PubMed ID: 15764824
[TBL] [Abstract][Full Text] [Related]
7. [Venous insufficiency and hemorheology. Influence of venous stasis on erythrocyte aggregation and disaggregation].
Le Devehat C; Vimeux M; Bertrand A
J Mal Vasc; 1989; 14(4):307-11. PubMed ID: 2584888
[TBL] [Abstract][Full Text] [Related]
8. Do hemorheological alterations play any role in the development of thrombotic events in Behçet's disease?
Vayá A; Ricart J; Todolí J; Micó L; Contreras T; Aznar J
Clin Hemorheol Microcirc; 2004; 30(3-4):411-4. PubMed ID: 15258375
[TBL] [Abstract][Full Text] [Related]
9. Impact of rheological variables in cancer.
von Tempelhoff GF; Heilmann L; Hommel G; Pollow K
Semin Thromb Hemost; 2003 Oct; 29(5):499-513. PubMed ID: 14631550
[TBL] [Abstract][Full Text] [Related]
10. Influence of lipids and obesity on haemorheological parameters in patients with deep vein thrombosis.
Vayá A; Falcó C; Simó M; Ferrando F; Mira Y; Todolí J; España F; Corella D
Thromb Haemost; 2007 Sep; 98(3):621-6. PubMed ID: 17849051
[TBL] [Abstract][Full Text] [Related]
11. Rheological properties of fetal red cells with special reference to aggregability and disaggregability analyzed by light transmission and laser backscattering techniques.
El Bouhmadi A; Boulot P; Laffargue F; Brun JF
Clin Hemorheol Microcirc; 2000; 22(2):79-90. PubMed ID: 10831059
[TBL] [Abstract][Full Text] [Related]
12. Initially metastatic breast carcinoma has a distinct disease pattern but an equivalent outcome compared with recurrent metastatic breast carcinoma.
Jimeno A; Amador ML; González-Cortijo L; Tornamira MV; Ropero S; Valentín V; Hornedo J; Cortés-Funes H; Colomer R
Cancer; 2004 May; 100(9):1833-42. PubMed ID: 15112263
[TBL] [Abstract][Full Text] [Related]
13. LEA-135 expression: its association with a lower risk of recurrence and increased overall survival of patients with lymph node-positive primary invasive breast cancer.
Saha B; Zhang N; Naritoku WY; Tsao-Wei DD; Groshen SL; Carlsson G; Larsson L; Gustavsson B; Chaiwun B; Taylor CR; Imam SA
Anticancer Res; 2004; 24(4):2391-400. PubMed ID: 15330189
[TBL] [Abstract][Full Text] [Related]
14. Hyperviscosity syndrome in patients with ovarian carcinoma.
von Tempelhoff GF; Heilmann L; Hommel G; Schneider D; Niemann F; Zoller H
Cancer; 1998 Mar; 82(6):1104-11. PubMed ID: 9506356
[TBL] [Abstract][Full Text] [Related]
15. Prognostic role of plasmaviscosity in breast cancer.
von Tempelhoff GF; Schönmann N; Heilmann L; Pollow K; Hommel G
Clin Hemorheol Microcirc; 2002; 26(1):55-61. PubMed ID: 11904471
[TBL] [Abstract][Full Text] [Related]
16. Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer.
Watari H; Todo Y; Takeda M; Ebina Y; Yamamoto R; Sakuragi N
Gynecol Oncol; 2005 Mar; 96(3):651-7. PubMed ID: 15721407
[TBL] [Abstract][Full Text] [Related]
17. Rheological profile in severe and morbid obesity. Preliminary results.
Solá E; Vayá A; Contreras T; Falcó C; Corella D; Hernández A; Aznar J
Clin Hemorheol Microcirc; 2004; 30(3-4):415-8. PubMed ID: 15258376
[TBL] [Abstract][Full Text] [Related]
18. Blood rheology during chemotherapy in patients with ovarian cancer.
von Tempelhoff GF; Niemann F; Schneider DM; Kirkpatrick CJ; Hommel G; Heilmann L
Thromb Res; 1998 Apr; 90(2):73-82. PubMed ID: 9684760
[TBL] [Abstract][Full Text] [Related]
19. CA125 level as a predictor of progression-free survival and overall survival in ovarian cancer patients with surgically defined disease status prior to the initiation of intraperitoneal consolidation therapy.
Juretzka MM; Barakat RR; Chi DS; Iasonos A; Dupont J; Abu-Rustum NR; Poynor EA; Aghajanian C; Spriggs D; Hensley ML; Sabbatini P
Gynecol Oncol; 2007 Jan; 104(1):176-80. PubMed ID: 16996584
[TBL] [Abstract][Full Text] [Related]
20. [Effects of cardiovascular risk factors on hemorheologic parameters in cerebrovascular patients].
Szapáry L; Szóts M; Horváth B; Márton Z; Alexy T; Késmárky G; Juricskay I; Nagy F; Gaál V; Pálfi A; Koltai K; Tóth K
Orv Hetil; 2003 Jun; 144(22):1085-90. PubMed ID: 12847818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]